Literature DB >> 21412835

Common variants in PARK loci and related genes and Parkinson's disease.

Sun Ju Chung1, Sebastian M Armasu, Joanna M Biernacka, Timothy G Lesnick, David N Rider, Sarah J Lincoln, Alexandra I Ortolaza, Matthew J Farrer, Julie M Cunningham, Walter A Rocca, Demetrius M Maraganore.   

Abstract

Rare mutations in PARK loci genes cause Parkinson's disease (PD) in some families and isolated populations. We investigated the association of common variants in PARK loci and related genes with PD susceptibility and age at onset in an outbred population. A total of 1,103 PD cases from the upper Midwest, USA, were individually matched to unaffected siblings (n = 654) or unrelated controls (n = 449) from the same region. Using a sequencing approach in 25 cases and 25 controls, single nucleotide polymorphisms (SNPs) in species-conserved regions of PARK loci and related genes were detected. We selected additional tag SNPs from the HapMap. We genotyped a total of 235 SNPs and two variable number tandem repeats in the ATP13A2, DJ1, LRRK1, LRRK2, MAPT, Omi/HtrA2, PARK2, PINK1, SNCA, SNCB, SNCG, SPR, and UCHL1 genes in all 2,206 subjects. Case-control analyses were performed to study association with PD susceptibility, while cases-only analyses were used to study association with age at onset. Only MAPT SNP rs2435200 was associated with PD susceptibility after correction for multiple testing (OR = 0.74, 95% CI = 0.64-0.86, uncorrected P < 0.0001, log additive model); however, 16 additional MAPT variants, seven SNCA variants, and one LRRK2, PARK2, and UCHL1 variants each had significant uncorrected P-values. There were no significant associations for age at onset after correction for multiple testing. Our results confirm the association of MAPT and SNCA genes with PD susceptibility but show limited association of other PARK loci and related genes with PD.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21412835      PMCID: PMC3606822          DOI: 10.1002/mds.23376

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  54 in total

1.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

2.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

3.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 5.  Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls.

Authors:  R F Potthoff
Journal:  Am J Epidemiol       Date:  1994-05-15       Impact factor: 4.897

6.  Random digit dialing in selecting a population-based control group.

Authors:  P Hartge; L A Brinton; J F Rosenthal; J I Cahill; R N Hoover; J Waksberg
Journal:  Am J Epidemiol       Date:  1984-12       Impact factor: 4.897

7.  Statistical methods in cancer research. Volume I - The analysis of case-control studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1980

8.  Validation of a telephone questionnaire for Parkinson's disease.

Authors:  W A Rocca; D M Maraganore; S K McDonnell; D J Schaid
Journal:  J Clin Epidemiol       Date:  1998-06       Impact factor: 6.437

9.  Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Authors:  Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew Farrer; Sarah Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan J Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; Dennis W Dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

10.  Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

Authors:  Coro Paisán-Ruíz; Shushant Jain; E Whitney Evans; William P Gilks; Javier Simón; Marcel van der Brug; Adolfo López de Munain; Silvia Aparicio; Angel Martínez Gil; Naheed Khan; Janel Johnson; Javier Ruiz Martinez; David Nicholl; Itxaso Martí Carrera; Amets Saénz Pena; Rohan de Silva; Andrew Lees; José Félix Martí-Massó; Jordi Pérez-Tur; Nick W Wood; Andrew B Singleton
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

View more
  20 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Authors:  Katerina Markopoulou; Joanna M Biernacka; Sebastian M Armasu; Kari J Anderson; J Eric Ahlskog; Bruce A Chase; Sun Ju Chung; Julie M Cunningham; Matthew Farrer; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2014-03-05       Impact factor: 4.891

3.  Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

Authors:  Joanna M Biernacka; Sebastian M Armasu; Julie M Cunningham; J Eric Ahlskog; Sun Ju Chung; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2011-08-03       Impact factor: 4.891

Review 4.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

5.  Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

Authors:  Sun Ju Chung; Sebastian M Armasu; Kari J Anderson; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Julie M Cunningham; J Eric Ahlskog; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2013-03-16       Impact factor: 4.891

6.  α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Authors:  Beate Ritz; Shannon L Rhodes; Yvette Bordelon; Jeff Bronstein
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

7.  A network view on Parkinson's disease.

Authors:  Sreedevi Chandrasekaran; Danail Bonchev
Journal:  Comput Struct Biotechnol J       Date:  2013-07-14       Impact factor: 7.271

8.  Alpha-synuclein repeat variants and survival in Parkinson's disease.

Authors:  Sun Ju Chung; Joanna M Biernacka; Sebastian M Armasu; Kari Anderson; Roberta Frigerio; Jan O Aasly; Grazia Annesi; Anna Rita Bentivoglio; Laura Brighina; Marie-Christine Chartier-Harlin; Stefano Goldwurm; Georgios Hadjigeorgiou; Barbara Jasinska-Myga; Beom Seok Jeon; Yun Joong Kim; Rejko Krüger; Suzanne Lesage; Katerina Markopoulou; George Mellick; Karen E Morrison; Andreas Puschmann; Eng-King Tan; David Crosiers; Jessie Theuns; Christine Van Broeckhoven; Karin Wirdefeldt; Zbigniew K Wszolek; Alexis Elbaz; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2014-02-27       Impact factor: 10.338

Review 9.  A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.

Authors:  Camilla Christina Pedersen; Johannes Lange; Marthe Gurine Gunnarsdatter Førland; Angus D Macleod; Guido Alves; Jodi Maple-Grødem
Journal:  NPJ Parkinsons Dis       Date:  2021-07-01

10.  LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration.

Authors:  Shiqing Zhang; Jiang Xie; Ying Xia; Shu Yu; Zhili Gu; Ruili Feng; Guanghong Luo; Dong Wang; Kai Wang; Meng Jiang; Xiao Cheng; Hai Huang; Wu Zhang; Tieqiao Wen
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.